Singapore markets close in 1 hour 41 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9038+0.0438 (+5.09%)
At close: 04:00PM EDT
0.8930 -0.01 (-1.19%)
After hours: 07:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 39.56M
Enterprise value -14.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)71.17
Price/book (mrq)1.56
Enterprise value/revenue -25.95
Enterprise value/EBITDA 0.29

Trading information

Stock price history

Beta (5Y monthly) 2.21
52-week change 3-69.04%
S&P500 52-week change 3-15.36%
52-week high 33.0500
52-week low 30.4610
50-day moving average 30.8835
200-day moving average 30.9681

Share statistics

Avg vol (3-month) 3128.58k
Avg vol (10-day) 382.91k
Shares outstanding 543.48M
Implied shares outstanding 6N/A
Float 827.74M
% held by insiders 15.43%
% held by institutions 150.24%
Shares short (14 Sept 2022) 4266.98k
Short ratio (14 Sept 2022) 42.38
Short % of float (14 Sept 2022) 40.81%
Short % of shares outstanding (14 Sept 2022) 40.61%
Shares short (prior month 14 Aug 2022) 4167.56k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,743.33%

Management effectiveness

Return on assets (ttm)-58.63%
Return on equity (ttm)-106.93%

Income statement

Revenue (ttm)1.9M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-89.80%
Gross profit (ttm)-29.75M
EBITDA -51.88M
Net income avi to common (ttm)-48.43M
Diluted EPS (ttm)-1.2350
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.32M
Total cash per share (mrq)0.7
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.21
Book value per share (mrq)0.58

Cash flow statement

Operating cash flow (ttm)-40.21M
Levered free cash flow (ttm)-19.85M